Single-cell analyses identify dysfunctional CD16<sup>+</sup> CD8 T cells in smokers.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 33163982.
- Also identified by DOI 10.1016/j.xcrm.2020.100054 and PMC identifier 7644053.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tobacco smoke exposure contributes to the global burden of communicable and chronic diseases. To identify immune cells affected by smoking, we use single-cell RNA sequencing on peripheral blood from smokers and nonsmokers. Transcriptomes reveal a subpopulation of <i>FCGR3A</i> (CD16)-expressing Natural Killer (NK)-like CD8 T lymphocytes that increase in smokers. Mass cytometry confirms elevated CD16<sup>+</sup> CD8 T cells in smokers. Inferred as highly differentiated by pseudotime analysis, NK-like CD8 T cells express markers characteristic of effector memory re-expressing CD45RA T (T<sub>EMRA</sub>) cells. Indicative of immune aging, smokers' CD8 T cells are biased toward differentiated cells and smokers have fewer naïve cells than nonsmokers. DNA methylation-based models show that smoking dose is associated with accelerated aging and decreased telomere length, a biomarker of T cell senescence. Immune aging accompanies T cell senescence, which can ultimately lead to impaired immune function. This suggests a role for smoking-induced, senescence-associated immune dysregulation in smoking-mediated pathologies.
Medical subject headings
- CD8-Positive T-Lymphocytes
- Cigarette Smoking
- Receptors, IgG